23andme Holding CO Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: 23andMe Holding Co. Sells Core Assets to Affiliate TTAM Research Institute for $302.5 Million Amidst Bankruptcy
23andMe Holding Co., currently undergoing Chapter 11 bankruptcy, has agreed to sell substantially all of its assets, including its genetic testing and Lemonaid businesses, to TTAM Research Institute, an affiliate of CEO Anne Wojcicki, for $302.5 million, pending Bankruptcy Court approval.
SCHEDULE 13D/A: Activist Investor Zentree and Richard Magides Take 18.2% Stake in 23andMe, Demand Governance Reforms and Cost Management
Activist investors Zentree Investments Limited and Richard Magides have disclosed an 18.2% beneficial ownership in 23andMe Holding Co., advocating for minority shareholder rights, prudent cost management, and equal treatment for Class A and Class B shares.
SCHEDULE 13D/A: Activist Investors Zentree and Richard Magides Disclose 16% Stake in 23andMe, Demand Governance Reforms and Cost Management
Zentree Investments Limited and Richard Magides have disclosed a 16.0% beneficial ownership stake in 23andMe Holding Co., signaling an activist intent to advocate for minority shareholder rights, improved cost management, and equal share class rights.
Activist investors Richard Magides and Zentree Investments Limited have disclosed a 13.0% beneficial ownership stake in 23andMe Holding Co., signaling an intent to advocate for minority shareholder rights, prudent cost management, and equal voting rights for all share classes.
SCHEDULE 13D/A: 23andMe CEO Anne Wojcicki Sweetens Buyout Offer with New Financing and Cost Cuts, Aims to Avert Bankruptcy
Anne Wojcicki, CEO of 23andMe Holding Co., has submitted an updated proposal to acquire all outstanding shares not owned by her and affiliates, maintaining the total consideration of up to $2.94 per share while offering new financing and committing to significant operating expense reductions to avoid bankruptcy.
SCHEDULE 13D/A: 23andMe Co-Founder Anne Wojcicki Proposes Take-Private Deal Valued at Up to $2.94 Per Share Amidst Bankruptcy Risk
23andMe Holding Co-founder Anne Wojcicki has submitted a revised non-binding proposal to acquire all outstanding shares not owned by her and affiliates for up to $2.94 per share, including upfront cash and contingent value rights, aiming to take the company private to avoid bankruptcy.
SCHEDULE 13D/A: 23andMe Founder Anne Wojcicki Proposes $0.41 Per Share Buyout to Take Company Private
23andMe Holding Co. founder Anne Wojcicki has submitted a non-binding proposal to acquire all outstanding shares not already owned by her and affiliates for $0.41 per share in cash, aiming to take the company private.
SCHEDULE 13D/A: 23andMe Receives $2.53 Per Share Take-Private Proposal from Co-Founder Anne Wojcicki and New Mountain Capital
23andMe Holding Co. has received a non-binding proposal from co-founder Anne Wojcicki and New Mountain Capital L.L.C. to acquire all outstanding shares not already owned by Ms. Wojcicki and her affiliates for $2.53 per share in cash.
SCHEDULE 13D/A: 23andMe CEO Anne Wojcicki Open to Third-Party Takeover Proposals, Revising Prior Stance
23andMe Holding Co. CEO Anne Wojcicki has reversed her previous position, indicating a willingness to consider third-party takeover proposals or other strategic alternatives for the company.